These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2225948)

  • 1. Quality of well-being before and after antibiotic treatment of pulmonary exacerbation in patients with cystic fibrosis.
    Orenstein DM; Pattishall EN; Nixon PA; Ross EA; Kaplan RM
    Chest; 1990 Nov; 98(5):1081-4. PubMed ID: 2225948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis].
    Magni A; Pradal U; Cazzola G; Mastella G
    Pediatr Med Chir; 1990; 12(5):531-4. PubMed ID: 2087426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quality of well-being in cystic fibrosis.
    Orenstein DM; Nixon PA; Ross EA; Kaplan RM
    Chest; 1989 Feb; 95(2):344-7. PubMed ID: 2914486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin therapy in cystic fibrosis.
    Raeburn JA; Govan JR; McCrae WM; Greening AP; Collier PS; Hodson ME; Goodchild MC
    J Antimicrob Chemother; 1987 Sep; 20(3):295-6. PubMed ID: 3680073
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T; Jahnke N; Harkensee C
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005405. PubMed ID: 17636796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of ofloxacin in cystic fibrosis patients].
    Romano L; Girosi D; Spallone E; Parisi F; Minicucci L; Romano C
    Minerva Pediatr; 1992 Mar; 44(3):79-86. PubMed ID: 1518497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pharmacokinetic aspects of ciprofloxacin in the treatment of acute exacerbations of pseudomonas infection in cystic fibrosis patients.
    Steen HJ; Scott EM; Stevenson MI; Black AE; Redmond AO; Collier PS
    J Antimicrob Chemother; 1989 Nov; 24(5):787-95. PubMed ID: 2599998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
    Esmond G; Butler M; McCormack AM
    J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic treatment of cystic fibrosis exacerbations].
    Dumcius S
    Medicina (Kaunas); 2003; 39(3):221-4. PubMed ID: 12695633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G; Jahnke N; Remmington T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home intravenous antibiotic treatment in cystic fibrosis.
    Strandvik B; Hjelte L; Widén B
    Scand J Gastroenterol Suppl; 1988; 143():119-20. PubMed ID: 3164495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
    BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. If you can't stand the rash, get out of the kitchen: an unusual adverse reaction to ciprofloxacin.
    Jaffé A; Bush A
    Pediatr Pulmonol; 1999 Dec; 28(6):449-50. PubMed ID: 10587421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of inhaled tobramycin in cystic fibrosis.
    Shteinberg M; Elborn JS
    Adv Ther; 2015 Jan; 32(1):1-9. PubMed ID: 25620537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Quality of Well-being Scale. Applications in AIDS, cystic fibrosis, and arthritis.
    Kaplan RM; Anderson JP; Wu AW; Mathews WC; Kozin F; Orenstein D
    Med Care; 1989 Mar; 27(3 Suppl):S27-43. PubMed ID: 2921885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin in cystic fibrosis.
    Smith MJ; Hodson ME; Batten JC
    Lancet; 1986 May; 1(8489):1103. PubMed ID: 2871373
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.
    Onakpoya IJ; Hayward G; Heneghan CJ
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011530. PubMed ID: 26408070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis.
    Langan KM; Kotsimbos T; Peleg AY
    Curr Opin Infect Dis; 2015 Dec; 28(6):547-56. PubMed ID: 26524327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.